Delivery Order SPE2DB22D2006-SPE2DB25FW4FC
- Not listed
- The Defense Logistics Agency awarded a $29,013.01 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,825.87 on April 21, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires delivery by April 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $28.8K to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units). This firm fixed-price contract, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive, non-set-aside purchase under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count units) valued at $41,479.72 under a firm fixed price contract type. The award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a competitive procurement with no set-aside designation. Performance of this pharmaceutical supply contract will be conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,069.22 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rifampin 150 mg capsules (30-count unit). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a single delivery order under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,655.95 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed price contract. The order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $14,989.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract, which is a non-set-aside competitive award, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,051.98 for 60 capsules of Rifampin 300 mg on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award, issued under firm fixed pricing, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a $77,696.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $4,160.15. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4FCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,324.76 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that provides a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive portfolio of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The contract structure reflects DLA's strategy to maintain flexible, long-term relationships with qualified pharmaceutical vendors capable of meeting diverse federal medical procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/15/25 |